Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

Vitamin D Receptor Gene Polymorphisms and the Risk of Metabolic Syndrome (MetS): A Meta-Analysis

Author(s): Hamidreza Totonchi, Ramazan Rezaei, Shokoofe Noori, Negar Azarpira*, Pooneh Mokarram* and Danyal Imani

Volume 21, Issue 5, 2021

Published on: 05 August, 2020

Page: [943 - 955] Pages: 13

DOI: 10.2174/1871530320666200805101302

Price: $65

Abstract

Background: Several studies have assessed the association between the vitamin D receptor (VDR) polymorphism and the risk of metabolic syndrome (MetS). However, the results were inconsistent and inconclusive. Therefore, we conducted a meta-analysis to clarify the exact association between the vitamin D receptor (VDR) polymorphisms and the risk of MetS.

Methods: All accessible studies reporting the association between the FokI (rs2228570) or/and TaqI (rs731236) or/and BsmI (rs1544410) or/and ApaI (rs7975232 polymorphisms of the Vitamin D Receptor and susceptibility to MetS published prior to February 2019 were systematically searched in Web of Science, Scopus, and PubMed. After that, Odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were estimated to evaluate the strength of the association in five genetic models.

Results: A total of 9 articles based on four gene variations, and comprising 3348 participants with 1779 metabolic syndrome patients were included. The overall results suggested a significant association between BsmI (rs1544410) polymorphism and MetS susceptibility in recessive model (OR, 0.72, 95% CI, 0.55-0.95, fixed effect model), allelic model (OR, 0.83, 95% CI, 0.72-0.95, fixed effect model), and bb vs BB (OR, 0.65, 95% CI, 0.46-0.93, fixed effect). However, no significant association was identified between TaqI (rs731236) polymorphism, ApaI (rs7975232) polymorphism, and FokI (rs2228570) polymorphism and MetS.

Conclusion: This meta-analysis suggested an association between the BsmI (rs1544410) polymorphism and MetS. Indeed, BsmI (rs1544410) acts as a protective factor in the MetS. As a result, the VDR gene could be regarded as a promising pharmacological and physiological target in the prevention or treatment of the MetS.

Keywords: VDR, Vitamin D receptor, metabolic syndrome, MetS, polymorphism, meta-analysis.

« Previous Next »
Graphical Abstract

[1]
Razi, B.; Alizadeh, S.; Omidkhoda, A.; Imani, D.; Rezaei, R. Association of chronic hepatitis B infection with metabolic syndrome and its components: Meta-analysis of observational studies. Diabetes Metab. Syndr., 2017, 11(Suppl. 2), S939-S947.
[http://dx.doi.org/10.1016/j.dsx.2017.07.020] [PMID: 28701286]
[2]
Kuneš, J.; Vaněčková, I.; Mikulášková, B.; Behuliak, M.; Maletínská, L.; Zicha, J. Epigenetics and a new look on metabolic syndrome. Physiol. Res., 2015, 64(5), 611-620.
[http://dx.doi.org/10.33549/physiolres.933174] [PMID: 26680230]
[3]
Hong, Y.; Pedersen, N.L.; Brismar, K.; de Faire, U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am. J. Hum. Genet., 1997, 60(1), 143-152.
[PMID: 8981957]
[4]
Qiao, Q.; Gao, W.; Zhang, L.; Nyamdorj, R.; Tuomilehto, J. Metabolic syndrome and cardiovascular disease. Ann. Clin. Biochem., 2007, 44(Pt 3), 232-263.
[http://dx.doi.org/10.1258/000456307780480963] [PMID: 17456293]
[5]
Wilson, P.W.; D’Agostino, R.B.; Parise, H.; Sullivan, L.; Meigs, J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 2005, 112(20), 3066-3072.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.539528] [PMID: 16275870]
[6]
Prasad, P.; Kochhar, A. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab. Syndr., 2016, 10(2), 105-112.
[http://dx.doi.org/10.1016/j.dsx.2015.02.014] [PMID: 25813139]
[7]
Chiu, K.C.; Chu, A.; Go, V.L.W.; Saad, M.F. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am. J. Clin. Nutr., 2004, 79(5), 820-825.
[http://dx.doi.org/10.1093/ajcn/79.5.820] [PMID: 15113720]
[8]
Liu, E.; McKeown, N.M.; Pittas, A.G.; Meigs, J.B.; Economos, C.D.; Booth, S.L.; Jacques, P.F. Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study. Eur. J. Clin. Nutr., 2012, 66(1), 139-141.
[http://dx.doi.org/10.1038/ejcn.2011.181] [PMID: 22009071]
[9]
Forman, J.P.; Giovannucci, E.; Holmes, M.D.; Bischoff-Ferrari, H.A.; Tworoger, S.S.; Willett, W.C.; Curhan, G.C. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension, 2007, 49(5), 1063-1069.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.087288] [PMID: 17372031]
[10]
Bell, N.H.; Epstein, S.; Greene, A.; Shary, J.; Oexmann, M.J.; Shaw, S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J. Clin. Invest., 1985, 76(1), 370-373.
[http://dx.doi.org/10.1172/JCI111971] [PMID: 2991340]
[11]
Demay, M.B. Mechanism of vitamin D receptor action. Ann. N. Y. Acad. Sci., 2006, 1068(1), 204-213.
[http://dx.doi.org/10.1196/annals.1346.026] [PMID: 16831920]
[12]
Haussler, M.R.; Whitfield, G.K.; Haussler, C.A.; Hsieh, J.C.; Thompson, P.D.; Selznick, S.H.; Dominguez, C.E.; Jurutka, P.W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res., 1998, 13(3), 325-349.
[http://dx.doi.org/10.1359/jbmr.1998.13.3.325] [PMID: 9525333]
[13]
Lohrer, H.D.; Tangen, U. Investigations into the molecular effects of single nucleotide polymorphism. Pathobiology, 2000, 68(6), 283-290.
[http://dx.doi.org/10.1159/000055939] [PMID: 11493762]
[14]
Risch, N.; Merikangas, K. The future of genetic studies of complex human diseases. Science, 1996, 273(5281), 1516-1517.
[http://dx.doi.org/10.1126/science.273.5281.1516] [PMID: 8801636]
[15]
Collins, F.S.; Guyer, M.S.; Charkravarti, A. Variations on a theme: cataloging human DNA sequence variation. Science, 1997, 278(5343), 1580-1581.
[http://dx.doi.org/10.1126/science.278.5343.1580] [PMID: 9411782]
[16]
Vélayoudom-Céphise, F-L.; Larifla, L.; Donnet, J-P.; Maimaitiming, S.; Deloumeaux, J.; Blanchet, A.; Massart, C.; Munoz-Bellili, N.; Merle, S.; Chout, R.; Bonnet, F.; Foucan, L. Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab., 2011, 37(6), 540-545.
[http://dx.doi.org/10.1016/j.diabet.2011.05.005] [PMID: 21764620]
[17]
Ortlepp, J.R.; Krantz, C.; Kimmel, M.; von Korff, A.; Vesper, K.; Schmitz, F.; Mevissen, V.; Janssens, U.; Franke, A.; Hanrath, P.; Zerres, K.; Hoffmann, R. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int. J. Cardiol., 2005, 105(1), 90-95.
[http://dx.doi.org/10.1016/j.ijcard.2005.03.004] [PMID: 16207551]
[18]
Wang, L.; Ma, J.; Manson, J.E.; Buring, J.E.; Gaziano, J.M.; Sesso, H.D. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur. J. Nutr., 2013, 52(7), 1771-1779.
[http://dx.doi.org/10.1007/s00394-012-0480-8] [PMID: 23262750]
[19]
Al-Daghri, N.M.; Guerini, F.R.; Al-Attas, O.S.; Alokail, M.S.; Alkharfy, K.M.; Draz, H.M.; Agliardi, C.; Costa, A.S.; Saulle, I.; Mohammed, A.K.; Biasin, M.; Clerici, M. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS One, 2014, 9(7)e102141
[http://dx.doi.org/10.1371/journal.pone.0102141] [PMID: 25020064]
[20]
Uitterlinden, A.G.; Fang, Y.; Van Meurs, J.B.; Pols, H.A.; Van Leeuwen, J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene, 2004, 338(2), 143-156.
[http://dx.doi.org/10.1016/j.gene.2004.05.014] [PMID: 15315818]
[21]
Karonova, T.; Grineva, E.; Belyaeva, O.; Bystrova, A.; Jude, E.B.; Andreeva, A.; Kostareva, A.; Pludowski, P. Relationship between vitamin D status and vitamin D receptor gene polymorphisms with markers of metabolic syndrome among adults. Front. Endocrinol. (Lausanne), 2018, 9, 448.
[http://dx.doi.org/10.3389/fendo.2018.00448] [PMID: 30166978]
[22]
Zhao, Y.; Liao, S.; He, J.; Jin, Y.; Fu, H.; Chen, X.; Fan, X.; Xu, H.; Liu, X.; Jin, J.; Zhang, Y. Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China. Lipids Health Dis., 2014, 13(1), 129.
[http://dx.doi.org/10.1186/1476-511X-13-129] [PMID: 25106919]
[23]
Sangkaew, B.; Nuinoon, M.; Jeenduang, N. Association of vitamin D receptor gene polymorphisms with serum 25(OH)D levels and metabolic syndrome in Thai population. Gene, 2018, 659, 59-66.
[http://dx.doi.org/10.1016/j.gene.2018.03.047] [PMID: 29555202]
[24]
Speer, G.; Cseh, K.; Winkler, G.; Vargha, P.; Braun, E.; Takács, I.; Lakatos, P. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur. J. Endocrinol., 2001, 144(4), 385-389.
[http://dx.doi.org/10.1530/eje.0.1440385] [PMID: 11275948]
[25]
Schuch, N.J.; Garcia, V.C.; Vívolo, S.R.G.F.; Martini, L.A. Relationship between vitamin D receptor gene polymorphisms and the components of metabolic syndrome. Nutr. J., 2013, 12(1), 96.
[http://dx.doi.org/10.1186/1475-2891-12-96] [PMID: 23855914]
[26]
Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med., 2010, 6(7)e1000097
[http://dx.doi.org/10.1016/j.ijsu.2010.02.007] [PMID: 19621072]
[27]
Zeng, X.; Zhang, Y.; Kwong, J.S.; Zhang, C.; Li, S.; Sun, F.; Niu, Y.; Du, L. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J. Evid. Based Med., 2015, 8(1), 2-10.
[http://dx.doi.org/10.1111/jebm.12141] [PMID: 25594108]
[28]
Higgins, J.P.; Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med., 2002, 21(11), 1539-1558.
[http://dx.doi.org/10.1002/sim.1186] [PMID: 12111919]
[29]
Mantel, N.; Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst., 1959, 22(4), 719-748.
[PMID: 13655060]
[30]
DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials, 1986, 7(3), 177-188.
[http://dx.doi.org/10.1016/0197-2456(86)90046-2] [PMID: 3802833]
[31]
Stuck, A.E.; Rubenstein, L.Z.; Wieland, D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 1998, 316(7129), 469.
[http://dx.doi.org/10.1136/bmj.316.7129.469] [PMID: 9492685]
[32]
Begg, C.B.; Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994, 50(4), 1088-1101.
[http://dx.doi.org/10.2307/2533446] [PMID: 7786990]
[33]
Khoja, S.O.; El Miedany, Y.; Iyer, A.P.; Bahlas, S.M.; Balamash, K.S.; Elshal, M.F. Association of the metabolic syndrome and vitamin D receptor gene polymorphisms: a cross sectional study. J. Exp. Biol. Agric. Sci., 2017, 5(6), 899-906.
[http://dx.doi.org/10.18006/2017.5(6).899.906]
[34]
Hasan, H.A.; AbuOdeh, R.O.; Muda, W.A.M.B.W.; Mohamed, H.J.B.J.; Samsudin, A.R. Association of vitamin D receptor gene polymorphisms with metabolic syndrome and its components among adult Arabs from the United Arab Emirates. Diabetes Metab. Syndr., 2017, 11(Suppl. 2), S531-S537.
[http://dx.doi.org/10.1016/j.dsx.2017.03.047] [PMID: 28392355]
[35]
Karuwanarint, P.; Phonrat, B.; Tungtrongchitr, A.; Suriyaprom, K.; Chuengsamarn, S.; Tungtronchitr, R. Genetic variations of vitamin D receptor gene in metabolic syndrome and related diseases in the Thai population. Asia Pac. J. Clin. Nutr., 2018, 27(4), 935-944.
[PMID: 30045441]
[36]
Mackawy, A.M.; Badawi, M.E. Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients. Meta Gene, 2014, 2, 540-556.
[http://dx.doi.org/10.1016/j.mgene.2014.07.002] [PMID: 25606437]
[37]
Ellison, T.I.; Dowd, D.R.; MacDonald, P.N. Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription. Mol. Endocrinol., 2005, 19(9), 2309-2319.
[http://dx.doi.org/10.1210/me.2004-0382] [PMID: 15919723]
[38]
Oh, J.; Riek, A.E.; Darwech, I.; Funai, K.; Shao, J.; Chin, K.; Sierra, O.L.; Carmeliet, G.; Ostlund, R.E., Jr; Bernal-Mizrachi, C. Deletion of macrophage vitamin D receptor promotes insulin resistance and monocyte cholesterol transport to accelerate atherosclerosis in mice. Cell Rep., 2015, 10(11), 1872-1886.
[http://dx.doi.org/10.1016/j.celrep.2015.02.043] [PMID: 25801026]
[39]
Cooper, J.D.; Smyth, D.J.; Walker, N.M.; Stevens, H.; Burren, O.S.; Wallace, C.; Greissl, C.; Ramos-Lopez, E.; Hyppönen, E.; Dunger, D.B.; Spector, T.D.; Ouwehand, W.H.; Wang, T.J.; Badenhoop, K.; Todd, J.A. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes, 2011, 60(5), 1624-1631.
[http://dx.doi.org/10.2337/db10-1656] [PMID: 21441443]
[40]
Hitman, G.A.; Mannan, N.; McDermott, M.F.; Aganna, E.; Ogunkolade, B.W.; Hales, C.N.; Boucher, B.J. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes, 1998, 47(4), 688-690.
[http://dx.doi.org/10.2337/diabetes.47.4.688] [PMID: 9568705]
[41]
Ye, W-Z.; Reis, A.F.; Dubois-Laforgue, D.; Bellanné-Chantelot, C.; Timsit, J.; Velho, G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur. J. Endocrinol., 2001, 145(2), 181-186.
[http://dx.doi.org/10.1530/eje.0.1450181] [PMID: 11454514]
[42]
Filus, A.; Trzmiel, A.; Kuliczkowska-Płaksej, J.; Tworowska, U.; Jędrzejuk, D.; Milewicz, A.; Medraś, M. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male, 2008, 11(3), 134-139.
[http://dx.doi.org/10.1080/13685530802273426] [PMID: 18821289]
[43]
Tworowska-Bardzińska, U.; Lwow, F.; Kubicka, E.; Łaczmański, Ł.; Jędzrzejuk, D.; Dunajska, K.; Milewicz, A. The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecol. Endocrinol., 2008, 24(9), 514-518.
[http://dx.doi.org/10.1080/09513590802302985] [PMID: 18958772]
[44]
Malecki, M.T.; Frey, J.; Moczulski, D.; Klupa, T.; Kozek, E.; Sieradzki, J. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp. Clin. Endocrinol. Diabetes, 2003, 111(8), 505-509.
[http://dx.doi.org/10.1055/s-2003-44711] [PMID: 14714273]
[45]
Valdivielso, J.M.; Fernandez, E. Vitamin D receptor polymorphisms and diseases. Clin. Chim. Acta, 2006, 371(1-2), 1-12.
[http://dx.doi.org/10.1016/j.cca.2006.02.016] [PMID: 16563362]
[46]
Laakso, M.; Sarlund, H.; Mykkänen, L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis, 1990, 10(2), 223-231.
[http://dx.doi.org/10.1161/01.ATV.10.2.223]]
[47]
Bland, R.; Markovic, D.; Hills, C.E.; Hughes, S.V.; Chan, S.L.; Squires, P.E.; Hewison, M. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J. Steroid Biochem. Mol. Biol., 2004, 89-90(1-5), 121-125.
[http://dx.doi.org/10.1016/j.jsbmb.2004.03.115] [PMID: 15225758]
[48]
Rahmadhani, R.; Zaharan, N.L.; Mohamed, Z.; Moy, F.M.; Jalaludin, M.Y. The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country. PLoS One, 2017, 12(6)e0178695
[http://dx.doi.org/10.1371/journal.pone.0178695] [PMID: 28617856]
[49]
Alvarez, J.A.; Ashraf, A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int. J. Endocrinol., 2010, 2010351385
[http://dx.doi.org/10.1155/2010/351385] [PMID: 20011094]
[50]
Grundberg, E.; Brändström, H.; Ribom, E.L.; Ljunggren, O.; Mallmin, H.; Kindmark, A. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur. J. Endocrinol., 2004, 150(3), 323-328.
[http://dx.doi.org/10.1530/eje.0.1500323] [PMID: 15012617]
[51]
Al-Daghri, N.M.; Al-Attas, O.S.; Alkharfy, K.M.; Khan, N.; Mohammed, A.K.; Vinodson, B.; Ansari, M.G.; Alenad, A.; Alokail, M.S. Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency. Gene, 2014, 542(2), 129-133.
[http://dx.doi.org/10.1016/j.gene.2014.03.044] [PMID: 24680778]
[52]
Kong, J.; Li, Y.C. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am. J. Physiol. Endocrinol. Metab., 2006, 290(5), E916-E924.
[http://dx.doi.org/10.1152/ajpendo.00410.2005] [PMID: 16368784]
[53]
Burton, G.R.; Guan, Y.; Nagarajan, R.; McGehee, R.E., Jr Microarray analysis of gene expression during early adipocyte differentiation. Gene, 2002, 293(1-2), 21-31.
[http://dx.doi.org/10.1016/S0378-1119(02)00726-6] [PMID: 12137940]
[54]
Chang, E.; Kim, Y. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes. Nutrition, 2016, 32(6), 702-708.
[http://dx.doi.org/10.1016/j.nut.2015.12.032] [PMID: 26899162]
[55]
Mazumdar, I.; Goswami, K.; Ali, M.S. Status of serum calcium, vitamin D and parathyroid hormone and hematological indices among lead exposed jewelry workers in Dhaka, Bangladesh. Indian J. Clin. Biochem., 2017, 32(1), 110-116.
[http://dx.doi.org/10.1007/s12291-016-0582-9] [PMID: 28149023]
[56]
Asemi, Z.; Foroozanfard, F.; Hashemi, T.; Bahmani, F.; Jamilian, M.; Esmaillzadeh, A. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin. Nutr., 2015, 34(4), 586-592.
[http://dx.doi.org/10.1016/j.clnu.2014.09.015] [PMID: 25300649]
[57]
Govers, M.J.; Van der Meet, R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut, 1993, 34(3), 365-370.
[http://dx.doi.org/10.1136/gut.34.3.365] [PMID: 8472985]
[58]
Ditscheid, B.; Keller, S.; Jahreis, G. Cholesterol metabolism is affected by calcium phosphate supplementation in humans. J. Nutr., 2005, 135(7), 1678-1682.
[http://dx.doi.org/10.1093/jn/135.7.1678] [PMID: 15987849]
[59]
Billington, E.O.; Bristow, S.M.; Gamble, G.D.; de Kwant, J.A.; Stewart, A.; Mihov, B.V.; Horne, A.M.; Reid, I.R. Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women. Osteoporos. Int., 2017, 28(1), 119-125.
[http://dx.doi.org/10.1007/s00198-016-3744-y] [PMID: 27543500]
[60]
Lurbe, E.; Agabiti-Rosei, E.; Cruickshank, J.K.; Dominiczak, A.; Erdine, S.; Hirth, A.; Invitti, C.; Litwin, M.; Mancia, G.; Pall, D.; Rascher, W.; Redon, J.; Schaefer, F.; Seeman, T.; Sinha, M.; Stabouli, S.; Webb, N.J.; Wühl, E.; Zanchetti, A. 2016 European society of hypertension guidelines for the management of high blood pressure in children and adolescents. J. Hypertens., 2016, 34(10), 1887-1920.
[http://dx.doi.org/10.1097/HJH.0000000000001039] [PMID: 27467768]
[61]
Asghari, G.; Yuzbashian, E.; Mirmiran, P.; Hooshmand, F.; Najafi, R.; Azizi, F. Dietary approaches to stop hypertension (DASH) dietary pattern is associated with reduced incidence of metabolic syndrome in children and adolescents. J. Pediatr., 2016, 174, 178-184.
[http://dx.doi.org/ 10.1016/j.jpeds.2016.03.077] [PMID: 27156186]
[62]
Lee, J.H.; O’Keefe, J.H.; Bell, D.; Hensrud, D.D.; Holick, M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol., 2008, 52(24), 1949-1956.
[http://dx.doi.org/10.1016/j.jacc.2008.08.050] [PMID: 19055985]
[63]
Steingrimsdottir, L.; Gunnarsson, O.; Indridason, O.S.; Franzson, L.; Sigurdsson, G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA, 2005, 294(18), 2336-2341.
[http://dx.doi.org/10.1001/jama.294.18.2336] [PMID: 16278362]
[64]
Snijder, M.B.; Lips, P.; Seidell, J.C.; Visser, M.; Deeg, D.J.; Dekker, J.M.; van Dam, R.M. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J. Intern. Med., 2007, 261(6), 558-565.
[http://dx.doi.org/10.1111/j.1365-2796.2007.01778.x] [PMID: 17547711]

Rights & Permissions Print Cite
Article Metrics
14
2
1
© 2024 Bentham Science Publishers | Privacy Policy